Evidence map›Paper›PMID 35363631›Full record

ArticleClinical and translational gastroenterology2022

Fecobionics Evaluation of Biofeedback Therapy in Patients With Fecal Incontinence.

Kaori Futaba, Ssu-Chi Chen, Wing Wa Leung, Cherry Wong, Tony Mak, Simon Ng, Hans Gregersen

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational gastroenterology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Fecobionics in proctology: review and perspectives.Surgery open digestive advance · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Kaori FutabaDepartment of Surgery, the Chinese University of Hong Kong, Shatin, Hong Kong.
Ssu-Chi ChenDepartment of Surgery, the Chinese University of Hong Kong, Shatin, Hong Kong.
Wing Wa LeungDepartment of Surgery, the Chinese University of Hong Kong, Shatin, Hong Kong.
Cherry WongDepartment of Surgery, the Chinese University of Hong Kong, Shatin, Hong Kong.
Tony MakDepartment of Surgery, the Chinese University of Hong Kong, Shatin, Hong Kong.
Simon NgDepartment of Surgery, the Chinese University of Hong Kong, Shatin, Hong Kong.
Hans GregersenDepartment of Surgery, the Chinese University of Hong Kong, Shatin, Hong Kong.
Chinese University of Hong Kong · CN

Funding

Neurophysiological mechanism in sacral neuromodulation in patients suffering from fecal incontinenceOT2OD028203 · OD · CALIFORNIA MEDICAL INNOVATIONS INSTITUTE · PI GREGERSEN, HANS · 2019 to 2021
$3.1M
NIH HHS OT2 OD028203
6 · The paper itself

Abstract

introductionBiofeedback therapy (BFT) is a well-known treatment for functional anorectal disorders. The effect of BFT was monitored in fecal incontinence (FI) patients with the Fecobionics test and with the conventional technologies, anorectal manometry (ARM) and balloon expulsion test (BET).

methodsStudies were performed in 12 patients before and after 8 weeks of biofeedback training. The Fecal Incontinence Severity Index (FISI) score was obtained. Anal resting and squeeze pressures were measured before the bag was distended in the rectum until urge to defecate. Pressure recordings were made during Fecobionics evacuation.

resultsBFT resulted in 24% reduction in FISI scores (P < 0.01). Seven patients were characterized as responders. Anal pressures, the urge-to-defecate volume, and defecatory parameters did not change significantly during BFT. For ARM-BET, the maximum anal squeeze pressure, the urge-to-defecate volume, and the expulsion time were lower after BFT compared with those before BFT (P < 0.05). For Fecobionics, the change in urge volume (r = 0.74, P < 0.05) and the change in defecation index (r = 0.79, P < 0.01) were associated with the change in FISI score. None of the ARM-BET parameters were associated with the change in FISI score. It was studied whether any pre-BFT data could predict treatment success. The Fecobionics expulsion duration and the defecation index predicted the outcome (P < 0.05). The defecation index had a sensitivity of 100% and a specificity of 72%. None of the ARM-BET parameters predicted the outcome (all P > 0.2). DISCUSSION: Fecobionics was used as a tool to monitor the effect of BFT and proved better than conventional technologies for monitoring and predicting the outcome in the FISI score.

Indexed as

Biofeedback, PsychologyDefecationFecal IncontinenceHumansManometrySeverity of Illness Index

Identifiers

PMID35363631
PMCPMC9132520
OpenAlexW4221042721

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.